New insights into iron regulation and erythropoiesis.

Abstract:

PURPOSE OF REVIEW:Iron homeostasis and erythropoiesis regulate each other to ensure optimal delivery of oxygen and iron to cells and tissues. Defining the mechanisms of this crosstalk is important for understanding the pathogenesis of common conditions associated with disordered iron metabolism and erythropoiesis. RECENT FINDINGS:Stress erythropoiesis causes suppression of hepcidin to increase iron availability for hemoglobin synthesis. The erythroid hormone erythroferrone (ERFE) was identified as the mediator of this process. ERFE and additional candidates (TWSG1 and GDF15) may also mediate hepcidin suppression in ineffective erythropoiesis. Several mechanisms by which iron regulates erythropoiesis were also recently identified. Iron deficiency suppresses erythropoietin production via the IRP1-HIF2α axis to prevent excessive iron usage by erythropoiesis during systemic iron restriction. Iron restriction also directly impairs erythroid maturation by inhibiting aconitase, and this can be reversed by the administration of the aconitase product isocitrate. Another novel target is GDF11, which is thought to autoinhibit erythroid maturation. GDF11 traps show promising pharmacologic activity in models of both ineffective erythropoiesis and iron-restricted anemia. SUMMARY:This review summarizes exciting advances in understanding the mechanisms of iron and erythropoietic regulation, and development of novel therapeutic tools for disorders resulting from dysregulation of iron metabolism or erythropoiesis.

journal_name

Curr Opin Hematol

authors

Kim A,Nemeth E

doi

10.1097/MOH.0000000000000132

subject

Has Abstract

pub_date

2015-05-01 00:00:00

pages

199-205

issue

3

eissn

1065-6251

issn

1531-7048

journal_volume

22

pub_type

杂志文章,评审
  • Peptide generation in the major histocompatibility complex class I antigen processing and presentation pathway.

    abstract::The bulk of antigens that are presented by major histocompatibility complex (MHC) class I molecules are processed in the cytosol. Therefore, the cellular protein degradation machinery is thought to play a major role in antigen processing. For example, there is clear evidence that the ubiquitin-proteasome pathway, the ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200101000-00003

    authors: Androlewicz MJ

    更新日期:2001-01-01 00:00:00

  • Antimicrobial peptides of leukocytes.

    abstract::Leukocytes use an array of antimicrobial peptides and proteins to help them destroy invading microorganisms. These endogenous antibiotic molecules are remarkable for their structural variety, rapid evolutionary divergence, intraspecies variation, and complex yet subtle interactions with their targets. This arsenal has...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199704010-00009

    authors: Ganz T,Lehrer RI

    更新日期:1997-01-01 00:00:00

  • 'Waterloo': when normal blood cells meet leukemia.

    abstract:PURPOSE OF REVIEW:Mortality and morbidity associated with leukemia are largely due to frequently occurring cytopenias or the dysfunction of normal blood cells in patients. Our knowledge of how normal blood cells degenerate in response to leukemic cell infiltration has been quite limited. This review summarizes recent f...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000253

    authors: Cheng H,Cheng T

    更新日期:2016-07-01 00:00:00

  • Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia.

    abstract::When a new product with huge clinical potential explodes on the scene, the hope is that the benefits far outweigh the risks in long-term administration. After 10 years of clinical use, granulocyte colony-stimulating factor (G-CSF) has lived up to that promise so far. In the context of severe chronic neutropenia, more ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199704030-00011

    authors: Freedman MH

    更新日期:1997-05-01 00:00:00

  • Genetics of type 1 von Willebrand disease.

    abstract:PURPOSE OF REVIEW:Type 1 von Willebrand disease (VWD) is the most common form of VWD, but has remained [corrected] the least well understood. Recent work is changing this situation. This review summarizes recent analysis of the genetic basis of the disease. RECENT FINDINGS:Linkage analysis demonstrates that dominantly...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e32826f4b41

    authors: Goodeve A

    更新日期:2007-09-01 00:00:00

  • Objectives and limitations of bloodless medical care.

    abstract:PURPOSE OF REVIEW:To outline the rationale, limitations, and execution of bloodless medical and surgical programs, highlighting characteristics that contribute to successful outcomes. RECENT FINDINGS:Clinical experiences with patients who refuse blood transfusions for religious reasons have provided valuable lessons a...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000245692.32085.bd

    authors: Shander A,Goodnough LT

    更新日期:2006-11-01 00:00:00

  • Human parvovirus B19 infection.

    abstract::Human parvovirus B19 shows remarkable tropism for human erythroid progenitor cells. The pathogenesis of disease resulting from infection is a dynamic between the viral suppression of erythropoiesis and the host's ability to mount an effective immune response. Understanding this process has led to strategies for treati...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199603020-00002

    authors: Carper E,Kurtzman GJ

    更新日期:1996-03-01 00:00:00

  • Patent foramen ovale and stroke: what should be done?

    abstract:PURPOSE OF REVIEW:The role of a patent foramen ovale (PFO) as a risk factor for ischemic stroke has been established in recent years. However, the best therapeutic option to prevent recurrent events is still controversial, with antithrombotic treatment or transcatheter PFO closure being favored by different clinicians....

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e32832d47dd

    authors: Di Tullio MR,Homma S

    更新日期:2009-09-01 00:00:00

  • Evidence based therapeutic apheresis in autoimmune and other hemolytic anemias.

    abstract:PURPOSE OF REVIEW:This article reviews recent publications that bear on the evidential basis for therapeutic apheresis in diseases in which hemolytic anemia is a prominent feature. RECENT FINDINGS:Therapeutic plasma exchange continues to be reported sporadically in severe autoimmune hemolytic anemia, with inconsistent...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3282c8ca66

    authors: McLeod BC

    更新日期:2007-11-01 00:00:00

  • Minimal residual disease monitoring in childhood acute lymphoblastic leukemia.

    abstract:PURPOSE OF REVIEW:This review summarizes recent advances in the application of minimal residual disease (MRD) testing in childhood acute lymphoblastic leukemia (ALL). RECENT FINDINGS:Polymerase chain reaction amplification of antigen receptor genes, one of the two main methods to study MRD in ALL, could be made more r...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3283543d5c

    authors: Campana D

    更新日期:2012-07-01 00:00:00

  • Role of constitutively activated protein tyrosine kinases in malignant myeloproliferative disorders: an update.

    abstract::Modern molecular technology helped identify more than 10 protein tyrosine kinases related to myeloid malignancies, which allowed the development of small molecule inhibitors targeting deregulated protein tyrosine kinase activity. Protein tyrosine kinase deregulation can occur as a consequence of fusion gene formation ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200301000-00007

    authors: Anastasiadou E,Schwaller J

    更新日期:2003-01-01 00:00:00

  • The use of granulocyte colony-stimulating factor for treatment of autoimmune neutropenia.

    abstract::The advent of better diagnostic tools, molecular techniques, and cytokine therapies have come together at the end of the 20th century to provide an improved outlook for patients with autoimmune neutropenia. Severe chronic neutropenia is no longer idiopathic in most cases, and growth factor therapy can be safely offere...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200105000-00007

    authors: Smith MA,Smith JG

    更新日期:2001-05-01 00:00:00

  • Clinical applications of stem cell factor.

    abstract::Stem cell factor is an early-acting hematopoietic cytokine that probably functions constitutively to support the proliferation and survival of pluripotent progenitor cells and to increase their receptivity to lineage commitment and differentiation in response to lineage-specific cytokines. Stem cell factor also can in...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199603030-00010

    authors: Glaspy J

    更新日期:1996-05-01 00:00:00

  • Progress and strategies for patients with relapsed and refractory acute myeloid leukemia.

    abstract:PURPOSE OF REVIEW:The treatment of patients with refractory or relapsed acute myeloid leukemia remains challenging. Management of these patients must take into account patient and leukemia-related factors in order to organize a comprehensive approach to treatment. Many new therapies are under study. RECENT FINDINGS:Ne...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e32801684ef

    authors: Litzow MR

    更新日期:2007-03-01 00:00:00

  • Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics.

    abstract:PURPOSE OF REVIEW:Despite parenteral artesunate therapy, the fatality rate of cerebral malaria remains high. Adjunctive therapy targeting the underlying pathophysiology of cerebral malaria may further improve the clinical outcome. Endothelial activation and dysfunction is a central process in the pathogenesis of cerebr...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e328345a4cf

    authors: Kim H,Higgins S,Liles WC,Kain KC

    更新日期:2011-05-01 00:00:00

  • Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications.

    abstract:PURPOSE OF REVIEW:Angioimmunoblastic T cell lymphoma is a complex lymphoproliferative disorder. While recent evidence suggests that the Epstein-Barr virus and B cell disregulation are implicated in the disease's pathogenesis, their mechanistic roles remain largely unknown. The prognosis with traditional chemotherapy ha...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e328186ffbf

    authors: Dunleavy K,Wilson WH,Jaffe ES

    更新日期:2007-07-01 00:00:00

  • Thrombopoietin and the humoral regulation of thrombocytopoiesis.

    abstract::In 1994 four biotechnology research groups reported the isolation and cloning of the ligand for the cytokine receptor c-Mpl and showed it to be the long-sought regulator of platelet production, thrombopoietin. Thrombopoietin is a hematopoietic growth factor of 332 amino acids composed of an amino terminal domain homol...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199502030-00002

    authors: Eaton DL,de Sauvage FJ

    更新日期:1995-05-01 00:00:00

  • Progress in the development of systems for in vitro expansion of human hematopoietic stem cells.

    abstract::Hematopoietic stem cells are the cells primarily responsible for short term and long term hematological reconstitution when a graft is infused into a myeloablated host. The number and quality of hematopoietic stem cells within a graft are the major determinants of the time to and durability of hematological reconstitu...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199905000-00010

    authors: Hoffman R

    更新日期:1999-05-01 00:00:00

  • Hemolysis and immune regulation.

    abstract:PURPOSE OF REVIEW:Hemolytic anemias caused by premature destruction of red blood cells occur in many disorders including hemoglobinopathies, autoimmune conditions, during infection or following reaction to drugs or transfusions. Recent studies which will be reviewed here have uncovered several novel mechanisms by which...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000423

    authors: Zhong H,Yazdanbakhsh K

    更新日期:2018-05-01 00:00:00

  • Monitoring minimal residual disease in patients with chronic myeloid leukemia after treatment with tyrosine kinase inhibitors.

    abstract:PURPOSE OF THE REVIEW:Monitoring for residual leukemic burden is an integral part of ongoing evaluation in chronic myeloid leukemia. With high rates of complete cytogenetic response induced by imatinib and other tyrosine kinase inhibitors, exploring refinements in current methods of minimal residual disease monitoring ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3282f42898

    authors: Sahay T,Schiffer CA

    更新日期:2008-03-01 00:00:00

  • Toll-like receptor signaling and atherosclerosis.

    abstract:PURPOSE OF REVIEW:Chronic inflammation and disordered lipid metabolism represent hallmarks of atherosclerosis. Considerable evidence has accumulated to suggest that innate immune defense mechanisms might interact with proinflammatory pathways and exacerbate or perhaps even initiate development of arterial plaques. Unti...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000219662.88409.7c

    authors: Michelsen KS,Arditi M

    更新日期:2006-05-01 00:00:00

  • Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases.

    abstract::Endothelial cell invasion is an essential event during angiogenesis (the formation of new blood vessels). This process involves the degradation of the extracellular matrix, the basement membrane, and interstitial stroma, and is governed by the activation of matrix metalloproteinases. However, the contribution of matri...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200303000-00007

    authors: Heissig B,Hattori K,Friedrich M,Rafii S,Werb Z

    更新日期:2003-03-01 00:00:00

  • Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.

    abstract:PURPOSE OF REVIEW:Therapy-related myelodysplastic syndromes and acute myelogenous leukemia (t-MDS/AML) comprise an increasingly common, poor-risk disease cohort without standard treatment options. This review describes available treatments and recent advances that may influence the clinical management of t-MDS/AML. RE...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e32835d82e6

    authors: Klimek VM

    更新日期:2013-03-01 00:00:00

  • Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells.

    abstract:PURPOSE OF REVIEW:The polycomb group gene BMI1 fulfills essential roles in both normal and leukemic stem cells. The underlying molecular mechanisms are beginning to become unraveled and an overview of the current knowledge on BMI1 signaling in normal and leukemic stem cells will be presented here. RECENT FINDINGS:In a...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e328338c439

    authors: Schuringa JJ,Vellenga E

    更新日期:2010-07-01 00:00:00

  • Purging marrow or peripheral blood stem cells for autografting.

    abstract::Myeloablative therapy followed by autologous bone marrow or peripheral blood stem cell rescue is an alternative therapeutic option for patients who are not candidates for allogeneic transplantation due to the lack of an appropriate HLA-matched donor or to advanced age. It allows therapy to be administered that is of c...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199704060-00011

    authors: Hammert LC,Ball ED

    更新日期:1997-11-01 00:00:00

  • Seasonal blood shortages can be eliminated.

    abstract:PURPOSE OF REVIEW:This review is designed to help readers understand seasonal blood shortages and provide solutions through the use of technology that can increase the number of red blood cell units collected and the use of recruitment and marketing initiatives that appeal to the increasingly diverse donor base. RECEN...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章

    doi:10.1097/01.moh.0000180436.98990.ce

    authors: Gilcher RO,McCombs S

    更新日期:2005-11-01 00:00:00

  • Stem cell transplantation for primary immune deficiency.

    abstract:PURPOSE OF REVIEW:In this article, we summarize the recent advances in treating primary immune deficiency (PID) disorders by stem cell transplantation (SCT); we have focused on articles published in the past 2 years since the last major review of SCT for PID. RECENT FINDINGS:Analyses of the outcomes of SCT for PID by ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e328365a13b

    authors: Worth AJ,Booth C,Veys P

    更新日期:2013-11-01 00:00:00

  • Genetic heterogeneity and clonal evolution in acute myeloid leukemia.

    abstract:PURPOSE OF REVIEW:Clonal heterogeneity is a significant obstacle to successful treatment of patients with acute myeloid leukemia (AML). Here, we review new advances in the understanding of genetic heterogeneity in AML using single-cell DNA-sequencing technology. RECENT FINDINGS:New genomics and immunologic discovery t...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章

    doi:10.1097/MOH.0000000000000626

    authors: Romer-Seibert JS,Meyer SE

    更新日期:2021-01-01 00:00:00

  • Is cure for chronic myeloid leukemia possible in the tyrosine kinase inhibitors era?

    abstract:PURPOSE OF REVIEW:The advent of tyrosine kinase inhibitors (TKI) has remarkably changed the treatment of chronic myeloid leukemia (CML). Patients treated in chronic phase can enjoy an expected survival similar to the general population. In the last few years we have found that some patients with an excellent therapeuti...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000224

    authors: Bansal A,Radich J

    更新日期:2016-03-01 00:00:00

  • Iron chelation: an update.

    abstract:PURPOSE OF REVIEW:This review provides an update on advances in the area of iron chelation therapy, including new indications and uses of currently available agents, and preliminary data on potential new agents in development. RECENT FINDINGS:Two new oral agents, deferasirox and deferiprone, have become available in t...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000031

    authors: Sheth S

    更新日期:2014-05-01 00:00:00